Literature DB >> 17073805

Insights into cytoprotection from ground squirrel hibernation, a natural model of tolerance to profound brain oligaemia.

Y-J Lee1, J M Hallenbeck.   

Abstract

Progression of acute ischaemic brain damage is complex and multifactorial. Also, evidence suggests that participating molecules and signal transduction pathways can function differently in different cellular contexts. Hibernation torpor, a model of natural tolerance to profoundly reduced blood flow and oxygen delivery to brain, along with models of induced ischaemic tolerance can guide efforts to identify cytoprotective mechanisms that are multifactorial and that target multiple mechanisms in multiple cellular contexts. Post-translational modification of proteins by conjugation with the SUMO (small ubiquitin-related modifier) is massively increased in hibernation and may be such a mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073805      PMCID: PMC1850989          DOI: 10.1042/BST0341295

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  28 in total

Review 1.  Cellular survival: a play in three Akts.

Authors:  S R Datta; A Brunet; M E Greenberg
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

Review 2.  The renaissance of GSK3.

Authors:  P Cohen; S Frame
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

3.  Hibernation, a model of neuroprotection.

Authors:  F Zhou; X Zhu; R J Castellani; R Stimmelmayr; G Perry; M A Smith; K L Drew
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 4.  The many faces of tumor necrosis factor in stroke.

Authors:  John M Hallenbeck
Journal:  Nat Med       Date:  2002-12       Impact factor: 53.440

Review 5.  Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling.

Authors:  Karen C Arden; William H Biggs
Journal:  Arch Biochem Biophys       Date:  2002-07-15       Impact factor: 4.013

6.  Ubc9 is essential for viability of higher eukaryotic cells.

Authors:  Tomoko Hayashi; Masayuki Seki; Daisuke Maeda; Wensheng Wang; Yoh-ichi Kawabe; Takahiko Seki; Hisato Saitoh; Tatsuo Fukagawa; Hideki Yagi; Takemi Enomoto
Journal:  Exp Cell Res       Date:  2002-11-01       Impact factor: 3.905

7.  Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16.

Authors:  M Imae; Z Fu; A Yoshida; T Noguchi; H Kato
Journal:  J Mol Endocrinol       Date:  2003-04       Impact factor: 5.098

8.  Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells.

Authors:  Yang-ja Lee; Shin-ichi Miyake; Hideaki Wakita; David C McMullen; Yoshiaki Azuma; Sungyoung Auh; John M Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2006-09-06       Impact factor: 6.200

9.  DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein.

Authors:  Hien Tran; Anne Brunet; Jill M Grenier; Sandeep R Datta; Albert J Fornace; Peter S DiStefano; Lillian W Chiang; Michael E Greenberg
Journal:  Science       Date:  2002-04-19       Impact factor: 47.728

Review 10.  Ischemic tolerance and endogenous neuroprotection.

Authors:  Ulrich Dirnagl; Roger P Simon; John M Hallenbeck
Journal:  Trends Neurosci       Date:  2003-05       Impact factor: 13.837

View more
  14 in total

1.  Expression of Nrf2 and its downstream gene targets in hibernating 13-lined ground squirrels, Spermophilus tridecemlineatus.

Authors:  Pier Morin; Zhouli Ni; David C McMullen; Kenneth B Storey
Journal:  Mol Cell Biochem       Date:  2008-03-10       Impact factor: 3.396

2.  CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury.

Authors:  Keri B Vartanian; Hugh D Mitchell; Susan L Stevens; Valerie K Conrad; Jason E McDermott; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-12       Impact factor: 6.200

3.  Small ubiquitin-related modifier (SUMO)-1 promotes glycolysis in hypoxia.

Authors:  Terence A Agbor; Alex Cheong; Katrina M Comerford; Carsten C Scholz; Ulrike Bruning; Ambrose Clarke; Eoin P Cummins; Gerard Cagney; Cormac T Taylor
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

4.  The Continued Promise of Neuroprotection for Acute Stroke Treatment.

Authors:  Shimin Liu; Steven R Levine
Journal:  J Exp Stroke Transl Med       Date:  2008

5.  Regional and temporal changes in proteomic profile after middle cerebral artery occlusion with or without reperfusion in rats.

Authors:  Hiroshi Yao; Tatsuo Nakahara; Nobuaki Nakagawa; Kijiro Hashimoto; Toshihide Kuroki
Journal:  Neurochem Res       Date:  2009-05-15       Impact factor: 3.996

Review 6.  Tumor necrosis factor and stroke: role of the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-08-06       Impact factor: 11.685

7.  Detecting endogenous SUMO targets in mammalian cells and tissues.

Authors:  Janina Becker; Sina V Barysch; Samir Karaca; Claudia Dittner; He-Hsuan Hsiao; Mauricio Berriel Diaz; Stephan Herzig; Henning Urlaub; Frauke Melchior
Journal:  Nat Struct Mol Biol       Date:  2013-03-17       Impact factor: 15.369

8.  Microarray profile of seizure damage-refractory hippocampal CA3 in a mouse model of epileptic preconditioning.

Authors:  S Hatazaki; C Bellver-Estelles; E M Jimenez-Mateos; R Meller; C Bonner; N Murphy; S Matsushima; W Taki; J H M Prehn; R P Simon; D C Henshall
Journal:  Neuroscience       Date:  2007-09-14       Impact factor: 3.590

9.  Condition-specific transcriptional regulation of neuronal ion channel genes in brain ischemia.

Authors:  Luisa Hernandez-Encarnacion; Pankaj Sharma; Roger Simon; An Zhou
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-12-25

Review 10.  Protein SUMOylation in neuropathological conditions.

Authors:  Dina B Anderson; Kevin A Wilkinson; Jeremy M Henley
Journal:  Drug News Perspect       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.